Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Should Income Investors Buy This Blue Chip Dividend Stock?


Elevated inflation has prompted numerous interest-rate hikes in the past 14 months. Rate hikes have led to eventual recessions the past seven or eight times that the Federal Reserve tried to tame inflation. As a result, 60% of economists surveyed in March said they believe the U.S. will experience a recession in the next 12 months.

So how should investors prepare? Aside from making sure they have an adequate emergency fund, buying blue chip dividend stocks would be a smart move because they tend to be less volatile in market downturns than their non-dividend-paying counterparts.

Bristol Myers Squibb (NYSE: BMY) is a solid dividend payer, but should investors buy the stock now? Let's examine the company's fundamentals and valuation to resolve this question.

Continue reading


Source Fool.com

Like: 0
BMY
Share

Comments